愛爾眼科(300015.SZ):擬2.79億元收購5家眼科醫院部分股權
格隆匯10月19日丨愛爾眼科(300015.SZ)公佈,公司擬收購南京愛爾安星眼科醫療產業投資中心(有限合夥)所持有的鞍山愛爾眼科醫院有限公司(簡稱“鞍山愛爾”)55%的股權、滄州愛爾眼科醫院有限公司(簡稱“滄州愛爾”)51%的股權、阜陽愛爾眼科醫院有限公司(簡稱“阜陽愛爾”)51%的股權、廊坊市愛爾眼科醫院有限公司(簡稱“廊坊愛爾”)72.7273%的股權、秦皇島愛爾眼科醫院有限公司(簡稱“秦皇島愛爾”)80%的股權。
該次收購的五家標的醫院均已形成良好的發展基礎,根據鞍山愛爾、滄州愛爾、阜陽愛爾、廊坊愛爾和秦皇島愛爾的資產評估報吿及現有的業務、人才和技術的基本情況,經交易各方協商一致,鞍山愛爾55%股權交易價格為4661.25萬元,滄州愛爾51%股權交易價格為8672.55萬元,阜陽愛爾51%股權交易價格為3938.22萬元,廊坊愛爾72.7273%股權交易價格為4727.27萬元,秦皇島愛爾80%股權交易價格為5905.60萬元。
收購完成後,公司將持有鞍山愛爾55%的股權,持有滄州愛爾51%的股權,持有阜陽愛爾51%的股權,持有廊坊愛爾72.7273%的股權,持有秦皇島愛爾80%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.